Abstract

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a mammary gland carcinogen present in the human diet in cooked meat. To examine if PhIP and its reactive metabolite N-hydroxy-PhIP inhibit apoptosis in human mammary epithelial MCF-10A cells, confluent cultures deprived of serum and growth factors were incubated for 24 h with either compound. The percentages of dead cells (mean ± SEM, n = 3) as measured by trypan blue exclusion were 5.7 ± 0.6, 3.4 ± 0.3, 2.7 ± 0.3, and 0.2 ± 0.003%, in control, 1 μM N-hydroxy-PhIP-, 5 μM N-hydroxy-PhIP-, and 100 μM PhIP-treated dishes, respectively. The expression of Bcl-2 and Bcl-xL as quantitated by Western blotting was 1.2- to 1.9-fold higher in the treated groups. PhIP–DNA adducts induced by N-hydroxy-PhIP in MCF-10A cells measured by the 32P-postlabeling assay were low (<1 × 107, relative adduct labeling). No adducts were detected after incubation with PhIP. Western blot analysis indicated that PhIP increased ERK2 phosphorylation concomitant with Bcl-2. The results suggest that the inhibition of cell death in mammary epithelial cells by PhIP occurs independently of PhIP–DNA adducts and may involve enhanced signaling through the MAP kinase pathways.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.